Special Seminar - Structural Biology Initiative: Robert Baffi
- Robert Baffi, PhD, Executive Vice President Technical Operations BioMarin Pharmaceutical, Inc.
- This presentation will address the clinical progress made to date on our gene therapy treatment (BMN 270) for Hemophilia A and correlate the relationship between product-related impurities (deamidation and empty capsids) to potency. In addition, the elements of a comparability assessment approach using a variety of analytical methods (RP-HPLC, Mass, Spectroscopy and Fluorescence Spectroscopy) will be presented allowing for the demonstration of comparability during process development.
November 9, 2018
12:00 PM — 1:00 PM
Advanced Science Research Center, GC/CUNY
85 St. Nicholas Terrace